References
Michel J, Langstein J, Hofstädter F, Schwarz H . A soluble form of CD137 (ILA/4-1BB) is released by activated lymphocytes and is detectable in sera of patients with rheumatoid arthritis. Eur J Immunol 1998; 28: 290–295.
Michel J, Schwarz H . Soluble CD137 is selectively expressed by T lymphocytes and correlates with activation induced cell death of lymphocytes. Cytokine 2000; 12: 742–746.
DeBenedette MA, Chu NR, Pollok KE, Hurtado J, Wade WF, Kwon BS et al. Role of 4-1BB ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP. J Exp Med 1995; 181: 985–992.
Hurtado JC, Kim SH, Pollok KE, Lee ZH, Kwon BS . Potential role of 4-1BB in T cell activation. Comparison with the costimulatory molecule CD28. J Immunol 1995; 155: 3360–3367.
Sharief MK . Heightened intrathecal release of soluble CD137 in patients with multiple sclerosis. Eur J Neurol 2002; 9: 49–54.
Jung HW, Choi SW, Choi JI, Kwon BS . Serum concentrations of soluble 4-1BB and 4-1BB ligand correlated with the disease severity in rheumatoid arthritis. Exp Mol Med 2004; 36: 13–22.
Martinsson U, Sundstrom C, Glimelius B . Immunophenotype analysis of B-CLL lymphoma and immunocytoma. APMIS 1989; 97: 1025–1032.
Stein H . Classification of non-Hodgkin's lymphomas on the basis of Morphological and immunological features shared by normal and neoplastic lymphatic cells. Immun Infekt 1976; 4: 52–69.
Acknowledgements
This work was supported by the German Cancer Research Foundation (Deutsche Krebshilfe).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Furtner, M., Straub, R., Krüger, S. et al. Levels of soluble CD137 are enhanced in sera of leukemia and lymphoma patients and are strongly associated with chronic lymphocytic leukemia. Leukemia 19, 883–885 (2005). https://doi.org/10.1038/sj.leu.2403675
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403675
- Springer Nature Limited
This article is cited by
-
Soluble CD137 and risk of hepatocellular carcinoma: nested case–control studies in cohorts in Shanghai and Singapore
British Journal of Cancer (2023)
-
Immunomodulation in leukemia: cellular aspects of anti-leukemic properties
Clinical and Translational Oncology (2020)
-
Regulation of CD137 expression through K‐Ras signaling in pancreatic cancer cells
Cancer Communications (2019)
-
Soluble immune checkpoints in cancer: production, function and biological significance
Journal for ImmunoTherapy of Cancer (2018)
-
CD137L dendritic cells induce potent response against cancer-associated viruses and polarize human CD8+ T cells to Tc1 phenotype
Cancer Immunology, Immunotherapy (2018)